The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Oxidative stress in Alzheimer’s disease
Open accessAbstract
Oxidative balance is emerging as an important issue in understanding the pathogenesis of Alzheimer's disease. Examination of Alzheimer's disease brain has demonstrated a great deal of oxidative damage, associated with both hallmark pathologies (senile plaques and neurofibrillary tangles) as well as in normal appearing pyramidal neurons. While this suggests that oxidative stress is a proximal event in Alzheimer's disease pathogenesis, the mechanisms by which redox balance is altered in the disease remains elusive. Determining which of the proposed sources of free radicals, which include mitochondrial dysfunction, amyloid-beta-mediated processes, transition metal accumulation and genetic factors like apolipoprotein E and presenilins, is responsible for redox imbalance will lead to a better understanding of Alzheimer's disease pathogenesis and novel therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All of these markers of OS have been described as an early alteration in the AD brain, and this concept has been used in the past to support the ‘oxidative stress hypothesis’ in the pathogenesis of AD [20,28,29,30].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [108]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Davis, R. E., Miller, S., Herrnstadt, C., Ghosh, S. S., Fahy, E., Shinobu, L. A., Galasko, D., Thal, L. J., Beal, M. F., Howell, N., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4526 · Cited by 341
RetractedCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,365
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Research works printed but not linked: 3
- Good, 1996, Am. J. Pathol., 149, 21
- Montine, 1996, Am. J. Pathol., 148, 89
- Cras, 1990, Am. J. Pathol., 137, 241
Cited by
Sorted by citations
Items 201–300 of 896
Choi, S., Kim, T., Kim, K. S., Kim, B.-Y., Ahn, S.-Y., Cho, H.-J., Lee, H. K., Cho, H., & Kim, E. K. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081001 · Cited by 82
Aliev, G., Smith, M. A., de la Torre, J. C., & Perry, G. L. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.018 · Cited by 84
Szabados, T., Dul, C., Majtényi, K., Hargitai, J., Pénzes, Z., & Urbanics, R. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.016 · Cited by 84
Shinomol, G. K., & ., M. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.03.002 · Cited by 83
Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
Dib, M., Garrel, C., Favier, A. E., Robin, V., & Desnuelle, C. (2002) · Journal of Neurology · doi:10.1007/s004150200025 · Cited by 84
“Oxidative stress in Alzheimer’s disease and its possible causes and consequences is more fully reviewed in Markesbery (1997) [70], Beal (1998) [7], Markesbery (1999) [71], Markesbery & Carney (1999) [72], Christen (2000) [19], Miranda et al. (2000) [79] and Smitha et al. (2000) [ 113 ].”
Nag, S., Fazio, P., Lehmann, L. E., Kettschau, G., Heinrich, T. K., Thiele, A., Svedberg, M. M., Amini, N., Leesch, S., Catafau, A. M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161083 · Cited by 83
Choi, H., Park, H., Koh, S., Choi, N.-Y., Yu, H., Park, J., Lee, Y. J., & Lee, K. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.12.005 · Cited by 82
Arunachalam, K., Yang, X., & San, T. T. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114540 · Cited by 82
Fracassi, A., Marcatti, M., Zolochevska, O., Tabor, N., Woltjer, R., Moreno, S., & Taglialatela, G. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.0295-20.2020 · Cited by 81
An okadaic acid-induced model of tauopathy and cognitive deficiency
Zhang, Z., & Simpkins, J. W. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.077 · Cited by 82
Weinreb, O., Amit, T., Mandel, S. A., Kupershmidt, L., & Youdim, M. B. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2929 · Cited by 80
Kim, J.-R., Lee, S.-R., Chung, H. J., Kim, S., Baek, S.-H., Kim, J. H., & Kim, Y.-S. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.53 · Cited by 78
An update on the interactions between Alzheimer's disease, autophagy and inflammation
Bostancıklıoğlu, M. (2019) · Gene · doi:10.1016/j.gene.2019.04.040 · Cited by 78
Dawn-Linsley, M., Ekinci, F. J., Ortiz, D., Rogers, E. J., & Shea, T. B. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.06.010 · Cited by 80
Oxidative inactivation of the proteasome in Alzheimer's disease
Cecarini, V., Ding, Q., & Keller, J. N. (2007) · Free Radical Research · doi:10.1080/10715760701286159 · Cited by 79
Hsp70.1 and related lysosomal factors for necrotic neuronal death
Yamashima, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07596.x · Cited by 79
Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim
Velmurugan, K., Alam, J., McCord, J. M., & Pugazhenthi, S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.050 · Cited by 80
Cu(II) interaction with N-terminal fragments of human and mouse β-amyloid peptide
Kowalik‐Jankowska, T. (2001) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00226-4 · Cited by 78
Wang, D., Ling, Z.-Q., Cao, F., Zhu, L., & Wang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00130.x · Cited by 77
González‐Domínguez, R., Sayago, A., & Fernández‐Recamales, Á. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.02.008 · Cited by 76
Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells
Oda, A., Tamaoka, A., & Araki, W. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22271 · Cited by 76
Montilla-López, P., Muñoz-Águeda, M. C., Feijóo, M., Muñoz-Castañeda, J. R., Bujalance, I., & Túnez‐Fiñana, I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02151-9 · Cited by 76
Intracellular A-Beta Amyloid, A Sign for Worse Things to Come?
Echeverría, V., & Cuello, A. C. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:299 · Cited by 81
Mullan, K., Williams, M. A., Cardwell, C. R., McGuinness, B., Passmore, P., Silvestri, G., Woodside, J. V., & McKay, G. J. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.06.006 · Cited by 79
Head, E. (2010) · AGE · doi:10.1007/s11357-010-9183-3 · Cited by 81
The Anti-apoptotic and Anti-oxidant Effect of Eriodictyol on UV-Induced Apoptosis in Keratinocytes
Lee, E.-R., Kim, J., Kang, Y.-J., & Cho, S. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.32 · Cited by 73
Inactivation and Reactivation of the Mitochondrial α-Ketoglutarate Dehydrogenase Complex
Shi, Q., Xu, H., Yu, H., Zhang, N., Ye, Y., Estévez, Á. G., Deng, H., & Gibson, G. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203018 · Cited by 72
Oxidative stress induces axonal beading in cultured human brain tissue
Roediger, B., & Armati, P. J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00038-x · Cited by 71
Protective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death
Moosmann, B., Skutella, T., Beyer, K., & Behl, C. (2001) · Biological Chemistry · doi:10.1515/bc.2001.195 · Cited by 70
Essential fatty acids are mediators of brain biochemistry and cognitive functions
Yehuda, S., Rabinovitz, S., & Mostofsky, D. I. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990615)56:6 · Cited by 285
Dietary Patterns Associated with Alzheimer’s Disease: Population Based Study
Gustaw‐Rothenberg, K. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6041335 · Cited by 69
Wang, D., Chen, C., Ke, X., Kang, N., Shen, Y., Liu, Y., Zhou, X., Wang, H., Chen, C., & Ren, L. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am5086269 · Cited by 69
Inherited neurodegenerative diseases: the one-hit model of neurodegeneration
Clarke, G. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.20.2269 · Cited by 69
Bar-Or, D., Thomas, G. W., Rael, L. T., Lau, E. P., & Winkler, J. V. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4533 · Cited by 68
Mitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86
Ellagic Acid and Its Anti-Aging Effects on Central Nervous System
Zhu, H., Yan, Y., Jiang, Y., & Meng, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810937 · Cited by 69
Effect of melatonin on calyculin A-induced tau hyperphosphorylation
Li, X., Wang, X., Zhang, J., Wang, Q., & Wang, J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.023 · Cited by 68
Kenchappa, R., Bodke, Y. D., Chandrashekar, A., et al. (2014) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2014.05.029 · Cited by 68
Wang, C., Guo, Y., Zhou, M., Xue, C., Chang, Y., Zhang, T., & Wang, Y. (2019) · Food & Function · doi:10.1039/c8fo01822g · Cited by 69
Antioxidant activity of Lactobacillus plantarum NJAU-01 in an animal model of aging
Ge, Q., Yang, B. K., Liu, R., Jiang, D., Yu, H., Wu, M., & Zhang, W. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02248-5 · Cited by 71
Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats
Limón, I. D., Díaz, A., Mendieta, L., Chamorro, G., Espinosa, B., Zenteno, E., & Guevara, J. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.11.006 · Cited by 68
Koh, C. H. V., & Cheung, N. S. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.04.006 · Cited by 67
Cardiolipin: characterization of distinct oxidized molecular species
Kim, J. H., Minkler, P. E., Salomon, R. G., Anderson, V. E., & Hoppel, C. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m010520 · Cited by 68
Ghribi, O., Herman, M. M., & Savory, J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10511 · Cited by 69
Benítez‐King, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00085-2 · Cited by 66
Synthesis, docking studies and antioxidant activity of some chalcone and aurone derivatives
Narsinghani, T., Sharma, M. C., & Bhargav, S. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0413-3 · Cited by 72
“…cancer (Kinnula and Crapo, 2004), cardiovascular diseases (Singh and Jialal, 2006), neural disorders (Sas et al., 2007), Alzheimer’s disease (Smith et al., 2000), mild cognitive impairment (Guidi et al., 2006), Parkinson’s disease (Bolton et al., 2000), alcohol-induced liver disease…”
Li, S., Zhao, X., Lazarovici, P., & Zheng, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1862437 · Cited by 67
Alzheimer’s Disease, Cholesterol, and Statins: The Junctions of Important Metabolic Pathways
Silva, T., Teixeira, J., Remião, F., & Borges, F. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204964 · Cited by 68
Quintanilla, R. A., Orellana, J. A., & Rommy von Bernhardi, M. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.016 · Cited by 67
Wei, X., Ma, Z., Fontanilla, C. V., Zhao, L., Xu, Z. C., Taggliabraci, V., Johnstone, B. H., Dodel, R. C., Farlow, M. R., & Du, Y. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.056 · Cited by 65
Antioxidant Activity of Galantamine and Some of its Derivatives
Tsvetkova, D. D., Obreshkova, D. P., Zheleva‐Dimitrova, D., & Saso, L. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990148 · Cited by 65
Transgenic Mouse Models of Alzheimer’s Disease: Behavioral Testing and Considerations
Bryan, K. J., Lee, H., Perry, G. L., Smith, M. A., & Casadesús, G. (2009) · Europe PMC (PubMed Central) · Cited by 64
Hirvonen, J., Kailajärvi, M., Haltia, T., Koskimies, S., Någren, K., Virsu, P., Oikonen, V., Sipilä, H. T., Ruokoniemi, P. T., Virtanen, K. A., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.241 · Cited by 64
Shea, T. B., & Rogers, E. J. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00412-6 · Cited by 65
Bomba, M., Granzotto, A., Castelli, V., ONOFRJ, M. C., Lattanzio, R., Cimini, A., & Sensi, S. L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-190237 · Cited by 65
Facheris, M., Beretta, S., & Ferrarese, C. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6210 · Cited by 61
Shirai, M., Kawai, Y., Yamanishi, R., Kinoshita, T., Chuman, H., & Terao, J. (2006) · Free Radical Research · doi:10.1080/10715760600794287 · Cited by 64
Gibson, G. E. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00802-x · Cited by 65
Luo, Y., Zhang, J., Liu, N., Luo, Y., & Zhao, B. (2011) · Science China Life Sciences · doi:10.1007/s11427-011-4180-z · Cited by 63
Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer s disease
Gibson, G. E. (2002) · Frontiers in bioscience · doi:10.2741/a827 · Cited by 63
Sasaki, N., Toda, T., Kaneko, T., et al. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00248-x · Cited by 63
Luo, W., Li, Y., He, Y., Huang, S., Li, D., Gu, L., & Huang, Z. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.03.058 · Cited by 64
Fonseca, S. F., Lima, D. B., Alves, D. A. C., Jacob, R. G., Perin, G., Lenardao, E. J., & Savegnago, L. (2015) · New Journal of Chemistry · doi:10.1039/c4nj02329c · Cited by 64
Chakrabarti, S., Sinha, M., Thakurta, I. G., Banerjee, P., & Chattopadhyay, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990152 · Cited by 63
Zatta, P. F., Tognon, G., & Carampin, P. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00058.x · Cited by 64
Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
Atlante, A., Amadoro, G., Bobba, A., & Latina, V. (2020) · Cells · doi:10.3390/cells9112347 · Cited by 67
Zhang, T., & Wong, G. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.018 · Cited by 64
Bioconjugates of cyclodextrins of manganese salen-type ligand with superoxide dismutase activity
Puglisi, A., Tabbı̀, G., & Vecchio, G. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.02.012 · Cited by 62
Kuperstein, F., & Yavin, E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02056.x · Cited by 62
Gibson, G. E., & Huang, H. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041764.45552.f3 · Cited by 66
Shi, Q., Xu, H., Kleinman, W. A., & Gibson, G. E. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.008 · Cited by 62
MiR-146a Regulates SOD2 Expression in H2O2 Stimulated PC12 Cells
Ji, G., Lv, K., Chen, H., Wang, T., Wang, Y., Zhao, D., Qu, L., & Li, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069351 · Cited by 61
Guan, Z.-Z. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00819.x · Cited by 61
Zhang, Z.-X., Li, Y., & Zhao, R. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2093-8 · Cited by 60
Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements
Poddar, J., Pradhan, M., Ganguly, G., & Chakrabarti, S. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.04.002 · Cited by 63
Cieślik, M., Czapski, G. A., Wójtowicz, S., Wieczorek, I., Wencel, P. L., Strosznajder, R. P., Jaber, V. R., Lukiw, W. J., & Strosznajder, J. B. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01819-y · Cited by 61
A novel rat gene encoding a Humanin‐like peptide endowed with broad neuroprotective activity
Caricasole, A., Bruno, V., Cappuccio, I., Melchiorri, D., Copani, A., & Nicoletti, F. (2002) · The FASEB Journal · doi:10.1096/fj.02-0018fje · Cited by 60
Chakraborty, S., Bandyopadhyay, J., Chakraborty, S., & Basu, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.057 · Cited by 59
Red wine micronutrients as protective agents in Alzheimer-like induced insult
Russo, A., Palumbo, M., Aliano, C., Lempereur, L., Scoto, G. M., & Renis, M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00123-1 · Cited by 60
Pugliese, M., Mascort, J., Mahy, N., & Ferrer, I. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0087-3 · Cited by 60
Chondroitin sulfate based nanocomplex for enhancing the stability and activity of anthocyanin
Jeong, D., & Na, K. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.05.072 · Cited by 60
Zou, J., Ainscough, J., Yang, W., Sedó, A., Yu, S., Mei, Z.-Z., Sivaprasadarao, A., Beech, D. J., & Jiang, L. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00390.2012 · Cited by 59
Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?
Teixeira, J., Silva, T., Andrade, P. B., & Borges, F. (2013) · Current Medicinal Chemistry · doi:10.2174/1871523011320240001 · Cited by 59
Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects
Shytle, R. D., Bickford, P. C., Rezai-Zadeh, K. P., Hou, L., Zeng, J., Tan, J., Sanberg, P. R., Sanberg, C. D., Roschek, B., Fink, R. C., et al. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147115 · Cited by 59
Ganji, A., Salehi, I., Nazari, M., Azandaryani, M. T., & Komaki, A. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0022-4 · Cited by 59
Bifenthrin-induced neurotoxicity in rats: involvement of oxidative stress
Syed, F., Awasthi, K. K., Chandravanshi, L. P., Verma, R., Rajawat, N. K., Khanna, V. K., John, P. J., & Soni, I. (2017) · Toxicology Research · doi:10.1039/c7tx00205j · Cited by 58
Tong, Y., Bai, L., Gong, R., Chuan, J., Duan, X., & Zhu, Y. (2018) · Scientific Reports · doi:10.1038/s41598-017-18058-7 · Cited by 60
Harris, J. R. (2002) · Micron · doi:10.1016/s0968-4328(02)00029-x · Cited by 59
Bar‐Am, O., Weinreb, O., Amit, T., & Youdim, M. B. H. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9139-6 · Cited by 58
“…Schliebs 2005); there is accumulating evidence that many cytotoxic signals in the AD brain can initiate apoptotic processes, including, oxidative stress (OS), inflammation, and accumulation of iron at the sites of neurodegeneration (Smith et al. 2000; Rogers and Lahiri 2004; Joseph et al. 2005).”
Lecanu, L., Greeson, J., & Papadopoulos, V. (2005) · Pharmacology · doi:10.1159/000088929 · Cited by 58
Catechol derivatives inhibit the fibril formation of amyloid-β peptides
Huong, V. T., Shimanouchi, T., Shimauchi, N., Yagi, H., Umakoshi, H., Goto, Y., & Kuboi, R. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2009.11.010 · Cited by 62
Vitamin E Forms in Alzheimer's Disease: A Review of Controversial and Clinical Experiences
Usoro, O. B., & Mousa, S. A. (2010) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802304222 · Cited by 70
Jeong, J. H., Jeong, H. R., Jo, Y. N., Kim, H. J., Shin, J. H., & Heo, H. J. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-268 · Cited by 56
Pretorius, E., Bester, J., & Kell, D. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160318 · Cited by 60
Qi, X., Xiu, J., Shan, K.-R., Xiao, Y. C., Gu, R., Liu, R., & Guan, Z.-Z. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.02.007 · Cited by 56
Generation of choline for acetylcholine synthesis by phospholipase D isoforms
Zhao, D., Frohman, M. A., & Blusztajn, J. K. (2001) · BMC Neuroscience · doi:10.1186/1471-2202-2-16 · Cited by 55
Mitochondria, Amyloid β, and Alzheimer′s Disease
Readnower, R. D., Sauerbeck, A. D., & Sullivan, P. G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/104545 · Cited by 58
Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42)
Everett, J. L., Brooks, J., Lermyte, F., O’Connor, P. B., Sadler, P. J., Dobson, J., Collingwood, J. F., & Telling, N. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-67117-z · Cited by 57
Lee, S.-H., Chen, Y., Chien, C.-C., Yan, Y., Chen, H., Chuang, H., Hsieh, H.-I., Cho, K.-H., Kuo, L., Chou, C. C. ‐., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254587 · Cited by 54
“Previous studies demonstrated that the increase in oxidative stress was a prominent early event that mediated AD pathogenesis [62, 63].”
Mbebi, C., Sée, V., Mercken, L., Pradier, L., Müller, U., & Loeffler, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107948200 · Cited by 53
Metadata
- Authors
- Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G.
- Affiliations
- Case Western Reserve University (US)
- Asahikawa Medical College Hospital (JP)
- Corresponding author
- Smith, Mark A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 1502
- Issue
- 1
- Pages
- 139-144
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W1983789627
- Cited by
- 895
- References
- 52
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 30 · 2023: 33 · 2022: 31 · 2021: 38 · 2020: 36 · 2019: 40 · 2018: 37 · 2017: 26 · 2016: 33 · 2015: 34 · 2014: 32 · 2013: 39 · 2012: 39
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Biochimica et Biophysica Acta
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- oxidative stress, Alzheimer's disease, redox imbalance, free radicals, mitochondrial dysfunction, amyloid-beta, apolipoprotein E, presenilin, amyloid plaques, neurofibrillary tangles, pyramidal neurons, pathogenesis
- MeSH terms
- Alzheimer Disease, Antioxidants, Free Radicals, Humans, Neurons, Oxidation-Reduction, Peptide Fragments, Amyloid beta-Peptides, Neurofibrillary Tangles, Oxidative Stress, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review